SYLOID® 244 FP meets the requirements of the monograph for silicon dioxide as stated in the latest USP/NF and Japanese Pharmaceutical Excipients(JPE) editions. The use of fumed silica as an excipient ingredient for pharmaceutical formulations, particularly in tablets and as a carrier for liquids is well known. However, compared with fumed silica, SYLOID® 244 FP silica is larger in particle size and has a higher density. This translates into a product that is much less dusty than fumed and is easier to handle and to incorporate into your formulation.

C-A-P CELLULOSE ESTER (PELLETS) (Cellulose Acetate Phthalate, NF) enteric coating material is a pH-sensitive cellulose derivative designed for coating pharmaceutical tablets, capsules or granules. It may also be used as a matrix material in solid dose forms. C-A-P enteric coating material withstands prolonged contact with acidic gastric fluids, but it dissolves readily in the mildly acidic to neutral environment of the small intestine. It can be applied to tablets, capsules or granules from solutions of organic solvents. C-A-P meets USP and NF specifications and is available in powder and pellet form.

C-A-P CELLULOSE ESTER (POWDER)(Cellulose Acetate Phthalate, NF) enteric coating material is a pH-sensitive cellulose derivative designed for coating pharmaceutical tablets, capsules or granules. It may also be used as a matrix material in solid dose forms. C-A-P enteric coating material withstands prolonged contact with acidic gastric fluids, but it dissolves readily in the mildly acidic to neutral environment of the small intestine. It can be applied to tablets, capsules or granules from solutions of organic solvents. C-A-P meets USP and NF specifications and is available in powder and pellet form.

CELLULOSE ACETATE (CA-398-10NF/EP) is a low viscosity solution grade of cellulose acetate. It is the most commonly used coating material as the semi-permeable membrane for osmotic (controlled-release) drug delivery. It is also used for taste-masking and tableting. CA-398-10NF/EP is made under cGMP and meets the requirements of the National Formulary (NF) and European Pharmacopoeia (EP). CA-398-10NF/EP is available in powder form.